Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2508857rdf:typepubmed:Citationlld:pubmed
pubmed-article:2508857lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:2508857lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:2508857lifeskim:mentionsumls-concept:C0441833lld:lifeskim
pubmed-article:2508857lifeskim:mentionsumls-concept:C0242618lld:lifeskim
pubmed-article:2508857lifeskim:mentionsumls-concept:C0032863lld:lifeskim
pubmed-article:2508857pubmed:issue6700lld:pubmed
pubmed-article:2508857pubmed:dateCreated1989-12-8lld:pubmed
pubmed-article:2508857pubmed:abstractTextMethods for determining sample size and power when comparing two groups in clinical trials are widely available. Studies comparing three or more treatments are not uncommon but are more difficult to analyse. A linear nomogram was devised to help calculate the sample size required when comparing up to five parallel groups. It may also be used retrospectively to determine the power of a study of given sample size. In two worked examples the nomogram was efficient. Although the nomogram offers only 5% and 1% significance levels and can be used only for up to five treatment groups, this is sufficient for most researchers.lld:pubmed
pubmed-article:2508857pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2508857pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2508857pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2508857pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2508857pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2508857pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2508857pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2508857pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2508857pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2508857pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2508857pubmed:languageenglld:pubmed
pubmed-article:2508857pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2508857pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2508857pubmed:statusMEDLINElld:pubmed
pubmed-article:2508857pubmed:monthSeplld:pubmed
pubmed-article:2508857pubmed:issn0959-8138lld:pubmed
pubmed-article:2508857pubmed:authorpubmed-author:GrahamD FDFlld:pubmed
pubmed-article:2508857pubmed:authorpubmed-author:DayS JSJlld:pubmed
pubmed-article:2508857pubmed:issnTypePrintlld:pubmed
pubmed-article:2508857pubmed:day9lld:pubmed
pubmed-article:2508857pubmed:volume299lld:pubmed
pubmed-article:2508857pubmed:ownerNLMlld:pubmed
pubmed-article:2508857pubmed:authorsCompleteYlld:pubmed
pubmed-article:2508857pubmed:pagination663-5lld:pubmed
pubmed-article:2508857pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2508857pubmed:meshHeadingpubmed-meshheading:2508857-...lld:pubmed
pubmed-article:2508857pubmed:meshHeadingpubmed-meshheading:2508857-...lld:pubmed
pubmed-article:2508857pubmed:meshHeadingpubmed-meshheading:2508857-...lld:pubmed
pubmed-article:2508857pubmed:meshHeadingpubmed-meshheading:2508857-...lld:pubmed
pubmed-article:2508857pubmed:meshHeadingpubmed-meshheading:2508857-...lld:pubmed
pubmed-article:2508857pubmed:meshHeadingpubmed-meshheading:2508857-...lld:pubmed
pubmed-article:2508857pubmed:year1989lld:pubmed
pubmed-article:2508857pubmed:articleTitleSample size and power for comparing two or more treatment groups in clinical trials.lld:pubmed
pubmed-article:2508857pubmed:affiliationDepartment of Epidemiology and Population Sciences, London School of Hygiene and Tropical Medicine.lld:pubmed
pubmed-article:2508857pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2508857lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2508857lld:pubmed